Schizophrenia (SCZ) is a central nervous system (CNS) disease which is characterized by thinking disorder, cognitive impairments and other clinical manifestations that alter daily functioning. SCZ currently does not have satisfactory treatment options to improve cognitive symptoms. Deeper understanding of the underlying mechanism is required for effective treatment of SCZ. Blood-brain barrier (BBB) is the immunological junction between brain and vascular circulation, and its disruption is associated with a number of CNS diseases. This study aims to investigate if the BBB is compromised in SCZ.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords